In:
Advanced Materials Research, Trans Tech Publications, Ltd., Vol. 926-930 ( 2014-5), p. 1073-1076
Abstract:
Abstract:Objective: To investigate whether any association exists between genetic polymorphism in CYP2B6 c.516G 〉 T and individual susceptibility to acute lymphoblastic leukemia (ALL). Methods: Our study group consisted of 96 ALL patients(T-ALL 17 cases, B-ALL 79 cases) and 348 unrelated healthy newborn volunteers as a control group. Genomic DNA was extracted from peripheral blood and cord blood leukocytes. We genotyped CYP2B6 c.516G 〉 T polymorphism by use of PCR with sequence-specific primers (PCR-SSP). The data were analyzed statistically using chi-square and logistic regression analyses. Results: The frequencies of GG genotype were 74.14%, 57.29%, 29.41% and 63.29%, and GT genotype were 23.85%, 37.50%, 64.71% and 31.65%, and TT genotype were 2.01%, 5.21%, 5.88% and 5.06% in control group, ALL, T-ALL, and B-ALL cases, respectively. Chi-square test showed a significant correlation between the CYP2B6 c.516G 〉 T polymorphism GT genotype and ALL patients (OR=2.035, 95%CI=1.249-3.313, P =0.004); and T-ALL patients (OR=6.839, 95%CI=2.309-20.252, P =0.000); whereas and B-ALL patients (OR=1.554, 95%CI=0.906-2.667, P =0.108). Conclusions: This study revealed the CYP2B6 c.516GT genotype may be a risk factor to the development of ALL, especially T-ALL.
Type of Medium:
Online Resource
ISSN:
1662-8985
DOI:
10.4028/www.scientific.net/AMR.926-930
DOI:
10.4028/www.scientific.net/AMR.926-930.1073
Language:
Unknown
Publisher:
Trans Tech Publications, Ltd.
Publication Date:
2014
detail.hit.zdb_id:
2265002-7
Permalink